Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Moodys
Express Scripts
Mallinckrodt
McKinsey

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Deproco Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for DEPROCO, and what generic and branded alternatives to DEPROCO drugs are available?

DEPROCO has six approved drugs.



Summary for Deproco
US Patents:0
Tradenames:5
Ingredients:4
NDAs:6

Drugs and US Patents for Deproco

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Deproco SEPTOCAINE articaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 020971-001 Apr 3, 2000 AP RX Yes Yes   Start Trial   Start Trial
Deproco SCANDONEST PLAIN mepivacaine hydrochloride INJECTABLE;INJECTION 088387-001 Oct 10, 1984 AP RX No Yes   Start Trial   Start Trial
Deproco LIGNOSPAN STANDARD epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088390-001 Jan 22, 1985 RX No Yes   Start Trial   Start Trial
Deproco SEPTOCAINE articaine hydrochloride; epinephrine bitartrate INJECTABLE;INJECTION 022010-001 Mar 30, 2006 AP RX Yes Yes   Start Trial   Start Trial
Deproco SCANDONEST L levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 088388-001 Oct 10, 1984 RX No Yes   Start Trial   Start Trial
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389-001 Jan 22, 1985 RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
McKinsey
AstraZeneca
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.